SOLICITATION NOTICE
B -- Protein Identification of Mixture Samples by LC/MS/MS and Proteomic Profiling of ASO treated Brain Organoids
- Notice Date
- 7/15/2024 6:49:33 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541380
— Testing Laboratories
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N95024Q00422
- Response Due
- 7/22/2024 9:00:00 AM
- Archive Date
- 08/06/2024
- Point of Contact
- Sarah Adan, Phone: 3014805422
- E-Mail Address
-
sarah.adan@nih.gov
(sarah.adan@nih.gov)
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is 75N95024Q00422 and the solicitation is issued as a request for quotation (RFQ). �� � This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13�Simplified Acquisition Procedures; �and FAR Part 12�Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). � The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Poochon Scientific LLC, 5350 Partners Court, STE. C, Frederick, MD 21703 for the Protein Identification of Mixture Samples by LC/MS/MS and Proteomic Profiling of ASO treated Brain Organoids. This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-1(b)(1). The Therapeutic Development Branch (TDB) at the National Center for Advancing Translational Sciences (NCATS) plans to use brain organoids derived from patient�s specific induce pluripotent stem cells (iPSC) as a model system in vitro to test new hypothesis, and establish diseases hallmarks by Liquid Chromatography with tandem mass spectrometry (LC/MS/MS). Furthermore, it will use the model system with proteomic profiling to validate the efficacy of potential therapeutic treatment such as antisense oligonucleotides (ASO). See Attachment 1 - Statement of Work.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/9647db9ff73b470bbadf84b0b6ac4e15/view)
- Place of Performance
- Address: Frederick, MD 21703, USA
- Zip Code: 21703
- Country: USA
- Zip Code: 21703
- Record
- SN07128082-F 20240717/240715230106 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |